Why the study?
Hypertrophic cardiomyopathy is the most common monogenic cardiovascular disorder, motivating the generation of disease-specific human induced pluripotent stem cell lines.
The successful generation of an hiPSC line from an HCM patient with an MYH7 mutation provides a valuable cellular model for studying the disease mechanisms of hypertrophic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
New hiPSC line enables HCM modeling; leaves open extension to hypertension insights or clinical use.
Hypertrophic cardiomyopathy (HCM) is the most common monogenic cardiovascular disorder. In this study, we generated human induced pluripotent stem cells (iPSC) ZZUNEUi007-A from dermal fibroblasts of an HCM patient with the p. R663H (c. 1988 G > A) mutation in MYH7. The generated hiPSC line had normal karyotype, showed robust expression of pluripotency markers and could differentiate into all three germ layers in vivo.
No takes yet. Share an insight, caveat, or question.
Li et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: